Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 15
1980 7
1981 6
1982 8
1983 10
1984 11
1985 13
1986 8
1987 11
1988 18
1989 10
1990 20
1991 19
1992 32
1993 15
1994 13
1995 13
1996 12
1997 7
1998 14
1999 3
2000 6
2001 6
2002 5
2003 7
2004 4
2005 3
2007 2
2010 1
2012 2
2013 1
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Results by year

Filters applied: . Clear all
Page 1
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Nolen TM. Nolen TM. Clin Infect Dis. 1992 Jun;14 Suppl 2:S255-63; discussion S272. doi: 10.1093/clinids/14.supplement_2.s255. Clin Infect Dis. 1992. PMID: 1617046 Review.
Three recently completed clinical studies have demonstrated some therapeutic advantages of cefprozil, a new broad-spectrum oral cephalosporin, over cefaclor and erythromycin in the treatment of skin and skin-structure infections. Specifically, cefprozil offers clinical eff …
Three recently completed clinical studies have demonstrated some therapeutic advantages of cefprozil, a new broad-spectrum oral cephalospori …
Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Pedersen SS. Pedersen SS. Scand J Infect Dis Suppl. 1989;60:89-97. Scand J Infect Dis Suppl. 1989. PMID: 2667111 Review.
Ciprofloxacin has been found to be superior in clinical efficacy to cefaclor. Experimental animal models suggest a role for ciprofloxacin in infections caused by Legionella pneumophila and Mycoplasma pneumoniae. ...
Ciprofloxacin has been found to be superior in clinical efficacy to cefaclor. Experimental animal models suggest a role for ciproflox …
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Kafetzis DA. Kafetzis DA. Eur J Clin Microbiol Infect Dis. 1994 Oct;13(10):857-65. doi: 10.1007/BF02111353. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7889960 Review.
In Study 3, cefprozil 30 mg/kg/day (b.i.d.) was compared to cefaclor 40 mg/kg/day (t.i.d.) and cefixime 8 mg/kg/day (q.d) in the treatment of acute otitis media in 388 pediatric patients. ...
In Study 3, cefprozil 30 mg/kg/day (b.i.d.) was compared to cefaclor 40 mg/kg/day (t.i.d.) and cefixime 8 mg/kg/day (q.d) in the trea …
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
Barbhaiya RH, Shukla UA, Gleason CR, Shyu WC, Wilber RB, Pittman KA. Barbhaiya RH, et al. Antimicrob Agents Chemother. 1990 Jun;34(6):1204-9. doi: 10.1128/AAC.34.6.1204. Antimicrob Agents Chemother. 1990. PMID: 2393282 Free PMC article. Clinical Trial.
However, the levels of cefprozil and cefaclor in skin blister fluid declined more slowly than they did in plasma. The skin blister fluid half-life estimates for cefprozil were significantly longer than they were for cefaclor. Parallel to the observation in plasma, t …
However, the levels of cefprozil and cefaclor in skin blister fluid declined more slowly than they did in plasma. The skin blister fl …
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
McCarty JM. McCarty JM. Eur J Clin Microbiol Infect Dis. 1994 Oct;13(10):846-50. doi: 10.1007/BF02111351. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7889958 Review.
In Study 2, the patients enrolled were 13 years of age and older, and cefprozil administered at 20 mg/kg once a day had similar clinical (93% vs. 90%) and bacteriological (95% vs. 94%) response rates as cefaclor administered three times a day. Study 3 demonstrated that cef …
In Study 2, the patients enrolled were 13 years of age and older, and cefprozil administered at 20 mg/kg once a day had similar clinical (93 …
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Stutman HR, Arguedas AG. Stutman HR, et al. Clin Infect Dis. 1992 Jun;14 Suppl 2:S204-8; discussion S209-11. doi: 10.1093/clinids/14.supplement_2.s204. Clin Infect Dis. 1992. PMID: 1617039 Review.
In two randomized clinical trials in children with otitis media, the efficacy and safety of cefprozil are compared to those of amoxicillin/clavulanate (n = 530) and of cefaclor and cefixime (n = 394). The rate of clinical cure or improvement was similar among patients rece …
In two randomized clinical trials in children with otitis media, the efficacy and safety of cefprozil are compared to those of amoxicillin/c …
Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis.
Randolph MF. Randolph MF. Chemotherapy. 1988;34(6):512-8. doi: 10.1159/000238617. Chemotherapy. 1988. PMID: 3243093 Clinical Trial.
The efficacy of cefadroxil once daily and cefaclor given 3 times daily was compared in 250 pediatric patients with group A beta-hemolytic streptococcal pharyngitis. ...These data were confirmed by the clinical findings; failure or clinical recurrence occurred in 4.6% of ce …
The efficacy of cefadroxil once daily and cefaclor given 3 times daily was compared in 250 pediatric patients with group A beta-hemol …
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
McCarty JM, Renteria A. McCarty JM, et al. Clin Infect Dis. 1992 Jun;14 Suppl 2:S224-30; discussion S231-2. doi: 10.1093/clinids/14.supplement_2.s224. Clin Infect Dis. 1992. PMID: 1617042 Review.
In the cefprozil-cefaclor trial, the pathogen eradication rate for evaluable patients receiving cefprozil was 83%, which was significantly better than that for patients receiving cefaclor (76%) (P = .035). The rate of satisfactory clinical response was similar with …
In the cefprozil-cefaclor trial, the pathogen eradication rate for evaluable patients receiving cefprozil was 83%, which was signific …
Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children.
Zuccotti G, Dauria E, Torcoletti M, Lodi F, Bernardo L, Riva E. Zuccotti G, et al. J Int Med Res. 2001 Jul-Aug;29(4):349-54. doi: 10.1177/147323000102900412. J Int Med Res. 2001. PMID: 11675909 Free article. Clinical Trial.
The aim of this study was to evaluate the efficacy of cefaclor in the prophylaxis of recurrent acute otitis media (AOM) in human immunodeficiency virus (HIV)-infected children. ...This suggests that cefaclor may be useful in the prophylaxis of recurrent AOM in HIV-i …
The aim of this study was to evaluate the efficacy of cefaclor in the prophylaxis of recurrent acute otitis media (AOM) in human immu …
Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children.
Harrison CJ, Chartrand SA, Pichichero ME. Harrison CJ, et al. Pediatr Infect Dis J. 1993 Jan;12(1):62-9. doi: 10.1097/00006454-199301000-00014. Pediatr Infect Dis J. 1993. PMID: 8417428 Clinical Trial.
At end of therapy subjects with definite pathogens exhibited a satisfactory clinical outcome in 26 of 36 (72%) ears for cefaclor and 40 of 48 (83%) ears for cefixime recipients (P = 0.12). For ears with beta-lactamase-producing isolates there were no (0 to 12) cefixime fai …
At end of therapy subjects with definite pathogens exhibited a satisfactory clinical outcome in 26 of 36 (72%) ears for cefaclor and …
305 results